The Cannabis ETF (THCX)
ARCA ARCA Primary 
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector. With the DEA hearing delayed until early 2025 and a possible Trump presidency adding uncertainty, cannabis businesses are preparing for what rescheduling to Schedule III could mean.
Top Cannabis Stocks to Watch After Thanksgiving: US Market Insights
The US cannabis industry continues to expand rapidly, making it an exciting sector to watch after Thanksgiving. Recent statistics highlight the industry's projected growth, with revenue expected to exceed $50 billion by 2026. Legalization efforts have also gained momentum, with over 20 states now permitting recreational use and others considering similar measures. Recent headline news includes discussions around federal legalization, which could significantly impact the market. Moreover, some lawmakers are revisiting the SAFE Banking Act to address cannabis-related financial barriers. These developments make it crucial for investors to identify stocks poised to benefit from these trends.
urban-gro Expands Cannabis Sector Offering with Launch of New Processing and Extraction Division
LAFAYETTE, CO / ACCESSWIRE / November 26, 2024 / urban-gro, Inc. (Nasdaq:UGRO) ("urban-gro" or the "Company"), an integrated professional services and Design-Build firm offering solutions to the Controlled Environment Agriculture ("CEA") and commercial sectors, today announced the launch of its new Processing and Extraction Division. Further expanding urban-gro's sector offering, this strategic expansion driven by client demand, delivers cutting-edge solutions designed to optimize cannabis facilities for post-harvest operations.
Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities
Cannabis stocks have faced significant challenges recently, driven by political uncertainty that has further weighed on a sector still struggling to regain its footing since the overhyped all-time highs of 2021.
Advanced Flower Capital: Get Paid 13.7% Per Year As The Cannabis Market Grows
Advanced Flower Capital offers a 13.7% dividend yield, which is covered by its distributable earnings per share. AFCG's cautious underwriting and strategic equity raises ensure resilience and capitalize on current market opportunities, despite potential regulatory changes. AFCG stock's valuation remains attractive with a price/book ratio near 1.0x and a 13.7% yield, though short-term downside risk exists based on my technical analysis.
Innovative Industrial Properties: Is U.S. Cannabis Now Uninvestable?
Innovative Industrial Properties is a triple net lease cannabis REIT with a 105-property portfolio, yielding 7.1% and trading at a near-record low valuation. IIPR's low leverage, with a debt-to-equity ratio of 0.15x and strong liquidity, significantly reduces investment risk despite industry uncertainties. The REIT's free cash flow exceeds its dividend payments, enabling opportunistic investments and potential future dividend increases.
Cause For Concern In Cannabis With A Few Rays Of Light
Q3 earnings reveal widespread concerns in the cannabis sector, with stagnated growth, shrinking margins, and diminished cash flow despite new markets like Ohio. Green Thumb Industries (GTI) stands out for disciplined capital allocation and strong performance, suggesting potential long-term value despite sector challenges.
Cannabis Industry Focus: Marijuana Stocks to Watch This Week
The US cannabis industry continues to grow despite facing regulatory and economic challenges. By 2030, analysts project the market will reach $57 billion, driven by increased legalization and consumer demand. Currently, 23 states have legalized recreational cannabis, while 38 permit medical use. Recent headlines indicate progress toward federal reform, including bipartisan discussions to reschedule cannabis under the Controlled Substances Act. These developments, though gradual, signal long-term potential for the cannabis market. As investors assess opportunities, keeping an eye on the top marijuana stocks can provide a strategic edge. Monitoring companies with strong fundamentals and a robust presence in key markets is essential.
Solventless Cannabis Brand, Port North, Expands Operations to Lune Rise Farms Facilities
TORONTO, ON / ACCESSWIRE / November 21, 2024 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera"orthe"Company") is pleased to announce its wholly-owned Cannabis brand subsidiary, Port North Inc., has entered into an agreement to expand production into Lune Rise Farms' facilities in South Bruce County, Ontario.
The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan
Canopy Growth Corporation‘s CGC strategy for capturing the U.S. cannabis market was the focal point of a recent fireside chat hosted by Zuanic & Associates . CEO David Klein and CFO Judy Hong provided insights into Canopy USA's (CUSA) growth strategy, financial projections and its significance for investors navigating the evolving cannabis industry.
Prediction: Tilray Brands Won't Be a Cannabis Company in 5 Years
Prediction: Tilray Brands Won't Be a Cannabis Company in 5 Years
The Top Canadian Cannabis Stocks for November 2024 Growth
The cannabis industry continues to gain momentum in North America, with Canadian cannabis companies at the forefront of global expansion. As of 2023, the U.S. cannabis industry is projected to surpass $40 billion in annual sales by 2025. This rapid growth reflects increasing legalization efforts and rising consumer acceptance of cannabis products. Recently, discussions around U.S. federal cannabis reform have resurfaced, sparking optimism among investors. These developments could unlock significant opportunities for Canadian companies with existing U.S. partnerships. However, navigating the cannabis market requires strategic planning. Using technical analysis to identify entry points and implementing proper risk management is essential for success.
